Abstract
The medical treatment of established deep venous thrombosis (DVT) includes thrombolytic agents and/or anticoagulants (heparins followed by oral antivitamin K agents).
Keywords
- Deep Vein Thrombosis
- Deep Venous Thrombosis
- Unfractionated Heparin
- Deep Venous Thrombosis Recurrence
- Post Phlebitic Syndrome
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abildgaard, U., Norrheim, L., Larsen A.E., Nesvold, A., Sandset, P.M., Odegaard, O.R., 1990. Monitoring therapy with LMW Heparin; a comparison of three chromogenic substrate assays and the Heptest clotting assay. Haemostasis 20:193–203.
Aiach, M. 1991. Should deep venous thrombosis treatment with low molecular weight heparin (Fragmin®) be monitored or not? Results of a randomized comparative multicentric french study. Thromb. Haemostas. 65:754, abst. 307.
Albada, J., Nieuwenhuis, H.K. and Sixma, J.J., 1989. Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin®): results of a double blind randomized study. Circulation. 80:935–940.
Anonyme, 1989. Traitement des thromboses veineuses profondes constituées. Etude comparative d’un fragment d’héparine de bas poids moléculaire (Fragmine®) administrée par voie sous-cutanée, et de l’héparine standard administrée par voie intraveineuse continue. Etude multicentrique. Rev. Med. Interne. 10:375-381.
Barritt, D.W., and Jordan, S.G., 1960. Anticoagulant drugs in the treatment of pulmonary embolism. Lancet 1:1309.
Bratt, G., Tornebohm, E., Granqvist, S., Aberg, W., Lockner, B., 1985. A comparison between low molecular weight heparin (Kabi 2165) and standard heparin in the intravenous treatment of deep venous thrombosis. Thromb. Haemostas. 54:813–817.
Bratt, G., Aberg, W., Johansson, M., Törnebohm, E., Granqvist, S., Lockner, D., 1990. Two daily subcutaneous injections of Fragmin as compared with intravenous standard heparin in the treatment of deep vein thrombosis (DVT). Thromb. Haemostas. 64:506–510.
Carter, C.J., Kelton, J.G., Hirsh, J., Cerskus, A., Santos, A.V., Gent, M., 1982. The relationship between the haemorrhagic properties of low molecular weight heparin in rabbits. Blood 59:1239–1245.
Duroux, P., 1991. A randomised trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis. A collaborative European Multicentre Study. Thromb. Haemostas. 65:251–256.
Elias, A., Lecorff, G., Bouvier, J.L., Aillaud, M.F., Juhan-Vague, I., Toulemonde, F., Serradimigni, A., 1986. Treatment of deep vein thrombosis by a very low molecular weight heparin fragment (CY 222): a dose range study. Thromb. Res, suppl. VI, 82, abst. 162.
Faivre, R., Neuhart, Y., Kieffer, Y., Apfel, F., Magnin, D., Didier, D., Toulemonde, F., Bassand, J.P., Maurat, J.P., 1988. Un nouveau traitement des thromboses veineuses profondes; les fractions d’héparine de bas poids moléculaire. Etude randomisée. Presse Med. 17:197–200.
Handeland, G.F., Abildgaard, U., Holm, H.A., Arnesen, K.E., 1990. Dose adjusted heparin treatment of deep venous thrombosis; a comparison of unfractionated and low molecular weight heparin. Eur. J. Clin. Pharmacol. 39:107–112.
Hommes, D.W., Bura, A., Mazzolat, L., Büller, H.R., ten Cate, J.W., 1991. Subcutaneous heparin compared to continuous intravenous heparin administration in the initial treatment of deep vein thrombosis: A systemic overview and meta-analysis. Thromb. Haemostas. 65:753, abst. 305.
Huet, Y., Gouault-Heilmann, M., Contant, G., Brun-Buisson, C., 1987. Treatment of acute pulmonary embolism by a low molecular weight heparin fraction. A preliminary study. Intensive Care Med. 13:126–130.
Hull, R.D., Raskob, G.E., Hirsh, J., Jay, R.M., Leclerc, J.R., Geerts, W.H., Rosenblum, D., Sackett, D.L., Anderson, C., Harrison, L., Gent, M., 1986. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N. Engl. J. Med. 315:1109–1114.
Hull, R.D., Raskob, G.E., Pineo, G.F., Green D., Trowbridge, A.A., Elliott, C.G. et al. 1991. A randomized double-blind trial of low-molecular weight heparin in the initial treatment of proximal-vein thrombosis. Thromb. Haemostas. 65:872. abst. 620.
Janvier, G., Dugrais, G., Winnock, S., Vergnes, C., Boisseau, M., Broussin, J., Serise, J.M., Boissieras, P., Videau, J., Toulemonde, F. 1987. Le CY 222, héparine de très bas poids moléculaire dans le traitement curatif des thromboses veineuses profondes. A propos de 95 observations. Résultats cliniques et phlébographiques. J. Mal. Vascul. 12:141–144.
Lane, D.A., Flynn, A., Ireland, H., Anastassiades, E., Curtis, J.R., 1986. On the evaluation of heparin and low molecular weight heparin in haemodialysis for chronic renal failure. Haemostasis 16(suppl. 2):38–47.
Lopaciuk, S., 1991. Activity of Fraxiparine® in the treatment of DVT. ISH-Xlth Meeting, Basel, August 31, Fraxiparine in the nineties”.
Pini, M., Pattacini, C., Quintavalla, R., Poli, T., Megha, A., Tagliaferri, A., Manotti, C., Dettori, A.G., 1990. Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis. A randomized Clinical Trial. Thromb. Haemostas. 64:222–226.
Prandoni, P., Vigo, M., Cattelan, A.M., Ruol, A. 1990. Treatment of deep venous thrombosis by fixed doses of a low-molecular weight heparin (CY 216). Haemostasis 20(suppl. l):220–223.
Prandoni, P., 1991. Fixed dose LMW Heparin (CY 216) as compared with adjusted dose intravenous heparin in the initial treatment of symptomatic proximal venous thrombosis. Thromb. Haemostas. 65:872, abst. 618.
Rogers, L.Q., Lutcher, C.L., 1990. Streptokinase therapy for deep vein thrombosis: a comprehensive review of the English literature. Am. J. Med. 88:389–395.
Samama, M, Desnoyers, P., 1991. Low-molecular-weight heparins and related glycosaminoglycans in the prophylaxis and treatment of venous thromboembolism, in: “Recent Advances in Blood Coagulation”, vol. 5. L. Poller, ed. Churchill Livingstone, Edinburgh. pp 177–222.
Siegbahn, A., Shams, Y-Hassan, Roberg, J., Bylund, H., Neerstrand, H.S., Ostergaard, P., Hedner, U., 1989. Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH-NOVO. Thromb. Res. 55:767–778.
Simonneau, G. 1991. Subcutaneous fixed dose of Enoxaparine (E) versus intravenous adjusted dose of unfractionated heparin (UH) in the treatment of deep venous thrombosis (DVT). TVPENOX Group Study. Thromb. Haemostas. 65: 754, abst. 306.
Turpie, A.G.G., Thrombolysis in deep vein thrombosis, in: “Thrombolysis in cardiovascular disease“ Julian, D.G., Kübier, W., Norris, R.M., Swan, H.J., Collen, D., Verstraete, M. eds., Marcel Dekker, Inc. New-York-Basel (1989) p.397–408.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Samama, MM. (1992). Treatment of Deep Vein Thrombosis (DVT) with Low Molecular Weight Heparins (LMWH). In: Lane, D.A., Björk, I., Lindahl, U. (eds) Heparin and Related Polysaccharides. Advances in Experimental Medicine and Biology, vol 313. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2444-5_27
Download citation
DOI: https://doi.org/10.1007/978-1-4899-2444-5_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-2446-9
Online ISBN: 978-1-4899-2444-5
eBook Packages: Springer Book Archive